Wogonin, as a potent anticancer compound: From chemistry to cellular interactions

• Published in: Experimental Biology and Medicine 2023-05, Vol.248 (9), p.820-828
• Main Authors: Tuli, Hardeep Singh, Rath, Prangya, Chauhan, Abhishek, Parashar, Gaurav, Parashar, Nidarshana Chaturvedi, Joshi, Hemant, Rani, Isha, Ramniwas, Seema, Aggarwal, Diwakar, Kumar, Manoj, Rana, Rashmi
• Format: Article
• Language: English
• Subjects: Antineoplastic Agents, Phytogenic - pharmacology; Drugs, Chinese Herbal - pharmacology; Humans; Neoplasms - drug therapy
• ISSN: 1535-3702; 1535-3699
• DOI: 10.1177/15353702231179961

Chinese native medicine Scutellaria baicalensis Georgi, also referred to as Chinese skullcap or Huang-Qin, is frequently used to treat cancer, viral infections, and seizures. This plant’s abundance of flavones (wogonoside) and their related aglycones (wogonin) is responsible for many of its pharmacologic effects. A significant ingredient in S. baicalensis that has been the subject of the most research is wogonin. Numerous preclinical investigations revealed that wogonin suppresses tumor growth by cell cycle arrest, stimulating cell death and preventing metastasis. This review focuses on a complete overview of published reports that suggest chemopreventive action of wogonin and the mechanistic insights behind these neoplastic activities. It also emphasizes the synergistic improvements made by wogonin in chemoprevention. The factual data in this mini-review stimulate additional research on chemistry and toxicological profile of wogonin to confirm its safety issues. This review will encourage researchers to generalize the merits of wogonin to be used as potential compound for cancer treatment.